Cognitive training for Attention Deficit Hyperactivity Disorder (ADHD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Attention Deficit Hyperactivity Disorder (ADHD)
Cognitive training - Other
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at how well cognitive training works for people with ADHD in Switzerland.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Attention Deficit Hyperactivity Disorder (ADHD)

Study Objectives

2 Primary · 5 Secondary · Reporting Duration: Change between two time points from baseline T1 to six week later T2 after cognitive training is assessed. Follow up is assessed at 3 months T3 and 6 months T4

Month 6
ADHD symptoms for adults
ADHD symptoms for children
Impulsivity
Neural activity
Reward
executive function
Month 6
Memory

Trial Safety

Safety Progress

1 of 3

Other trials for Attention Deficit Hyperactivity Disorder (ADHD)

Trial Design

3 Treatment Groups

active control group low-intensity
1 of 3
control healthy participants
1 of 3
experimental training group cognitive training
1 of 3
Active Control
Experimental Treatment

240 Total Participants · 3 Treatment Groups

Primary Treatment: Cognitive training · No Placebo Group · N/A

experimental training group cognitive training
Other
Experimental Group · 1 Intervention: Cognitive training · Intervention Types: Other
active control group low-intensity
Other
ActiveComparator Group · 1 Intervention: Cognitive training · Intervention Types: Other
control healthy participantsNoIntervention Group · 1 Intervention: control healthy participants · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change between two time points from baseline t1 to six week later t2 after cognitive training is assessed. follow up is assessed at 3 months t3 and 6 months t4

Who is running the clinical trial?

Paris West University Nanterre La DéfenseOTHER
5 Previous Clinical Trials
1,138 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
60 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
University of FribourgLead Sponsor
7 Previous Clinical Trials
779 Total Patients Enrolled
Martin Soelch Chantal, PRPrincipal InvestigatorUniversity of Fribourg
Amélie Dentz, Ph.DPrincipal InvestigatorUniversity of Fribourg

Eligibility Criteria

Age Any Age · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have ADHD and your diagnosis is confirmed by a specialist.
An IQ score of 80 or above is considered above average for adults, children, and adolescents, according to the Wechsler Intelligence Scales.
We obtained written consent from all participants and their legal guardians, if they were minors under the age of 14.
No ADHD diagnosis by a specialist is required for a child to qualify for services
This text refers to people aged between 6 and 65 years old.
We asked the participants and their legal guardians to sign an informed consent form to ensure that they understood the study and agreed to take part.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: October 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Pennsylvania50.0%
Oregon25.0%
New York25.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Dentz Amélie100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria50.0%
Met criteria50.0%